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Aims: The prognostic role (if any) of lactate for early mortality in patients with ST-elevation
myocardial infarction (STEMI) submitted to primary percutaneous coronary intervention (PCI) is so
far not elucidated. We therefore assessed whether lactic acid (LA) was a prognostic predictor for
early mortality in 807 patients with STEMI submitted to primary PCI consecutively admitted to our
intensive cardiac care unit (ICCU) from January 1, 2006, to December 31, 2009.
Result: Higher levels of LA were found in older patients (P = .025) and were associated with a
progressive decline in estimated glomerular filtration rate (P b .001) and in ejection fraction (P b
.001). The increase in LA values paralleled the progressive increase in glucose values, peak
glycemia, troponin I, N-terminal pro–brain natriuretic peptide, and uric acid (P b .001, P b .001,
P b .001, P = .018, and P = .006, respectively). The in-ICCU mortality rate was highest in the third
LA tertile (P b .001). Lactate levels were independent predictors for in-hospital mortality only in
patients with Killip classes III to IV (odds ratio [OR], 1.17; 95% confidence interval [CI], 1.05-1.30,
P = .003). In addition, age (OR, 1.11; 95% CI, 1.03-1.19, P = .006) and leukocytes (OR, 1.17; 95%
CI, 1.03-1.33, P = .015) were independent predictors for in-hospital mortality when adjusted for
PCI failure.
Conclusion: In patients with STEMI submitted to primary PCI, blood lactate is a prognostic marker
for early mortality only in the subgroup with advanced Killip class. The degree of hemodynamic
impairment (as indicated by Killip class), of myocardial ischemia (as inferred by troponin I), and
glucose values are the main factors influencing lactate concentrations in the early phase of STEMI.
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Hyperlactatemia is known as a marker of the metabolic
stress response and its severity is associated with
increased mortality in critically patients [1-3]. Lactate
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diagnostic and prognostic tool, have been equated mainly
with inadequate tissue oxygenation. Despite that most
studies have been performed in patients with signs of
clinical shock, elevated blood lactate levels have been
associated with a higher mortality even in hemodynam-
ically stable patients because they may indicate occult
hypoperfusion [4-6].
Few studies investigated the prognostic role of lactate in
patients with acute ischemic heart disease. Chiolero et al [7]
described hyperlactatemia in patients in cardiogenic shock
(CS) in the early postoperative period after heart surgery
and concluded that hyperlactatemia could mainly be related
to increased tissue lactate production. Koreny et al [8]
observed that peak serum lactate was a significant
univariate predictor of in-hospital mortality in patients
who develop acute renal failure during the first 24 hours of
CS after acute myocardial infarction. Contrasting are the
data on the prognostic role of lactate in these patients.
Geppert et al [9] found, in a retrospective study in 38 CS
patients, that interleukin-6 concentrations (and not lactate)
were an independent predictor of 30-day mortality.
Conversely, in 45 consecutive patients with CS complica-
ting STEMI and submitted to optimal treatment (repre-
sented by percutaneous coronary intervention [PCI] and
stent implantation, use of glycoprotein IIb/IIIa inhibitors,
intra-aortic balloon pump, mechanical ventilation, and
ultrafiltration, when needed), we documented [10] that
hyperlactatemia (N6.5 mmol/L) was an independent indi-
cator of in-hospital mortality.
The prognostic role (if any) of lactate for early mortality
in patients with ST-elevation myocardial infarction (STEMI)
submitted to primary PCI is so far not elucidated. We
therefore assessed whether lactic acid (LA) was a prognostic
predictor for early mortality in 807 STEMI patients
submitted to primary PCI consecutively admitted to our
intensive cardiac care unit (ICCU) from January 1, 2006, to
December 31, 2009.2. Methods
2.1. Study population
From January 1, 2006, to December 31, 2009, 807
consecutive patients with STEMI (within 12 hours from
symptoms' onset) were admitted to our ICCU, which is
located at a tertiary center.
In our hospital, in Florence, the reperfusion strategy of
patients with STEMI is represented by primary PCI [10-12].
Patients are first evaluated by the medical emergency system
staff in the prehospital setting and then directly admitted to
the catheterization laboratory or transferred to it after a rapid
stabilization in the emergency department. After primary
PCI, they are admitted to our ICCU.A successful procedure was defined as an infarct artery
stenosis less than 20% associated with Thrombolysis In
Myocardial Infarction grade 3 flow. Failure PCI was
defined as resulting in Thrombolysis In Myocardial
Infarction grade 0 to 2 flow, regardless the residual
stenosis [10,11].
The diagnosis of STEMI was based on the criteria of
the American College of Cardiology/American Heart
Association [12].
On ICCU admission, after PCI, in a fasting blood sample,
the following parameters were measured: glucose (g/L),
troponin I (ng/mL), uric acid (mg/dL) [13], N-terminal pro–
brain natriuretic peptide (NT-proBNP) (pg/mL) [11],
leukocyte count (×103/μL), fibrinogen (mg/dL), erythrocyte
sedimentation rate, glycated hemoglobin (%), cholesterol
(mg/dL), triglycerides (mg/dL), alanine aminotransferase
(U/L), aspartate aminotransferase (U/L). Creatinine (mg/dL)
was also measured to calculate glomerular filtration rate (mL
min−1 1.73 m−2). Glucose values and troponin (Tn I) were
measured 3 times a day (ie, at 6:00 AM, 12 noon, and 6:00 PM,
respectively) and peak glucose and peak Tn I were
considered [14], respectively. Blood lactate was collected
on ICCU admission.
Transthoracic 2-dimensional echocardiography was per-
formed on ICCU admission to measure left ventricular
ejection fraction.
In-ICCU mortality was considered as outcome.
The study was approved by an appropriate ethical
committee, and all patients gave informed consent to participate.3. Statistical analysis
Data have been processed by means of the SPSS 13.0
statistical package (SPSS Inc, Chicago, Ill). A P value less
than .05 was considered statistically significant. Data are
reported as frequencies (percentages) and medians (95%
confidence interval [CI]) and analyzed by means of χ2 (or
Fisher exact text, when appropriate) and Mann-Whitney U
test, respectively. Moreover, the study population has been
divided by tertiles of LA levels to investigate which variables
differed between the 3 subgroups by means of Kruskal-
Wallis or χ2. A linear regression analysis investigated the
correlation of insulin vs glycemia. By means of 2
multivariable backward linear regression analyses, we
explored the adjusted correlations of LA with clinical and
biochemical variables; the respective final models have been
reported. Logistic regression analysis was carried out
considering as outcomes intra-ICCU mortality. In this
multivariable analysis, candidate variables were chosen as
those that resulted significantly different at univariable
analysis and/or clinically relevant. Backward procedure
(probability for entry, .05; probability for removal, .10)
was repeated until all variables in the model reached
statistical significance.
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Our population comprises 807 consecutive patients with
STEMI submitted to primary PCI (Table 1). Males were
more frequent (73.2%), and anterior myocardial infarction
was the most frequent localization (56.4%). The incidence of
PCI failure was 7.1% and the in-ICCU mortality rate was
6.1%. Tertiles of LA are shown in Table 2. Higher levels of
LA were found in older patients (P = .025) and were
associated with a progressive decline in estimated glomerular
filtration rate (P b .001) and in ejection fraction (P b .001).
Killip classes III to IV and a higher incidence of PCI failure
were more frequent in the highest LA tertile (P b .001 and
P b .001, respectively). The increase in LA values paralleled
the progressive increase in glucose values, peak glycemia,
Tn I, NT-proBNP, and uric acid (P b .001, P b .001, P b
.001, P = .018, and P = .006, respectively). The highest
values of leukocytes and of fibrinogen were detectable in the
third LA tertile (P b .001 and P = .010, respectively). The in-
ICCU mortality rate was highest in the third LA tertile (P b
.001). As depicted in Fig. 1, admission lactate was
significantly higher in patients in Killip classes III to IV inTable 1 Clinical characteristics of 807 patients with STEMI
included in the study
Median (25th-75th percentile)
or frequency (%)
Age (y) 68 (58-77)
Male/female (%) 591/216 (73.2%/26.8%)
History of
Diabetes mellitus (n [%]) 175 (21.7%)
Smoking (n [%]) 496 (61.5%)
COPD (n [%]) 69 (8.6%)
Previous PCI (n [%]) 104 (12.9%)
Previous MI (n [%]) 114 (14.1%)
Hypertension (n [%]) 421 (52.2%)
Estimated GFR
(mL min−1 1.73 m−2)
77.7 (62.5-92.1)
AMI location (n [%])
Anterior 455 (56.4%)
Inferior 291 (36.1%)
Other 61 (7.6%)
Coronary artery disease (n [%])
No disease 1 (0.1%)
One-vessel 304 (37.7%)
Two-vessel 285 (35.3%)
Three-vessel 217 (26.9%)
LM involvement (n [%]) 58 (7.2%)
CABG involvement (n [%]) 10 (1.2%)
PCI failure (n [%]) 42 (5.2%)
Admission EF (%) 45 (35-50)
Latency (min) 240 (175-345)
In-hospital mortality (n [%]) 49 (6.1%)
COPD indicates chronic obstructive pulmonary disease; MI, myocardial
infarction; GFR, glomerular filtration rate; AMI, acute myocardial
infarction; CABG, coronary artery bypass graft; EF, ejection fraction.respect to those in Killip classes I to II. Table 3 shows the
variables significantly correlated with lactate at multivariable
linear regression analysis.
At multivariable backward logistic regression analysis,
in the overall population, the following variables were
independent predictors for in-ICCU mortality when
adjusted for age and uric acid: Tn I (odds ratio [OR],
1.004; 95% CI, 1.001-1.007; P = .004), NT-proBNP
(100 U/step) (OR, 1.009; 95% CI, 1.002-1.016; P = .014),
leukocytes (1000/mL) (OR, 1.218; 95% CI, 1.039-1.428;
P = .015) (Hesmer-Lemershow goodness-of-fit χ2, 3.222;
P = .920. pseudo r2, 0.455).
Table 4 shows multivariable backward logistic regression
analysis according to Killip classes. Lactate levels were
independent predictors for in-hospital mortality only in
patients with Killip classes III to IV (OR, 1.17; 95% CI, 1.05-
1.30; P = .003), In addition, age (OR, 1.11; 95% CI, 1.03-
1.19; P = .006) and leukocytes (OR, 1.17; 95% CI,
1.03-1.33; P = .015) were associated with in-hospital
mortality when adjusted for PCI failure (pseudo r2, 0.37;
Hesmer-Lemershow goodness-of-fit χ2, 3.25; P = .917).5. Discussion
In the present investigation performed in a large series of
patients with STEMI submitted to mechanical revascula-
rization, we documented, for the first time, that lactate values
are independent predictor for in-ICCU mortality only in the
subgroup of patients in advanced Killip classes. Moreover,
we observed that the degree of hemodynamic impairment (as
indicated by Killip class), of myocardial ischemia (as inferred
by Tn I), and glucose values are the main factors influencing
lactate concentrations in the early phase of STEMI.
The mechanisms regulating the rates of lactate production
vary in different disease states. During exercise, hyperlacta-
temia clearly results from imbalance between oxygen
delivery and energy requirements. In critically ill patients,
the genesis of hyperlactatemia is quite more complex,
including regional hypoperfusion, an inflammation-induced
up-regulation of glycolysis, alterations in lactate-clearing
mechanisms, and the increased work of breathing [15]. In
patients with CS, a marked increase in endogenous lactate
production was reported and lactate clearance was nonsig-
nificantly different in these patients from that of healthy
subjects [7,16]. In our investigation, the relationship between
Killip class, peak Tn I, and lactate strongly suggests that in
patients with STEMI submitted to PCI, lactate levels may be
mainly related to hemodynamic impairment and thus to
increased lactate production. According to our data, in
STEMI treated with mechanical revascularization, the
prognostic role of lactate stems from its relation with
hemodynamic derangement because it was an independent
predictor for early mortality only in patients with advanced
Killip class, even when adjusted for PCI failure. In this
Table 2 Tertiles of LA in our population
First tertile
(≤1.3 mmol/L; n = 278)
Second tertile
(1.3-1.9 mmol/L; n = 272)
Third tertile
(N1.9 mmol/L; n = 257)
P Kruskal-Wallis
H or χ2
Males/females 199/79 (71.6/28.4%) 213/59 (78.3/21.7%) 179/78 (69.6/30.4%) .059
Age (y) 66.5 (57.0-76.0) 67.5 (58.0-76.0) 71.0 (59.5-79.0) .025
BMI (kg/m2) 25.7 (23.3-27.6) 26.3 (24.4-28.4) 26.0 (23.8-28.4) .008
Estimated GFR
(mL min−1 1.73 m−2)
84.0 (67.5-98.7) 76.6 (64.8-89.9) 70.7 (49.8-88.1) b.001
AMI anterior (%) 143 (51.4%) 157 (57.7%) 155 (60.3%) .102
Killip class b.001
I-II 264 (94.6%) 249 (91.9%) 188 (73.2%)
III-IV 15 (5.4%) 22 (8.1%) 69 (26.8%)
EF (%) 45 (40-52) 45 (38-50) 40 (35-50) b.001
PCI failure 5 (1.8%) 13 (4.8%) 24 (9.4%) .002
Glucose (g/L) 1.21 (1.06-1.45) 1.32 (1.12-1.62) 1.66 (1.31-2.30) b.001
Peak glucose (g/L) 1.38 (1.21-1.65) 1.54 (1.27-1.97) 1.86 (1.50-2.54) b.001
HbA1c N6.5% (n = 568) 34 (21.0%) 34 (21.3%) 46 (27.9%) .249
Peak Tn I (ng/mL) 63.35 (27.89-133.60) 89.50 (36.78-158.50) 106.00 (49.87-239.04) b.001
NT-proBNP (pg/mL) 1398 (553-3306) 1188 (496-3000) 1932 (595-6047) .018
Uric acid (mg/dL) 5.3 (4.1-6.5) 5.5 (4.5-6.5) 5.8 (4.8-6.8) .006
ESR (mm/h) 30 (15-46) 25 (15-42) 30 (15-48) .154
Leucocytes (×103/μL) 10.3 (8.4-12.6) 10.9 (9.0-14.0) 12.7 (10.2-16.1) b.001
hs-CRP positivity 119 (51.1%) 101 (43.0%) 114 (56.2%) .020
Fibrinogen (mg/dL) 401 (341-506) 380 (322-453) 384 (312-470) .010
ALT (U/L) 31 (20-48) 35 (22-57) 45 (28-79) b.001
AST (U/L) 75 (34-158) 85 (44-184) 107 (56-248) b.001
GGT (U/L) 25 (18-43) 31 (21-55) 33 (22-56) b.001
Length of stay (h) 52 (47-75) 51 (47-75) 62 (43-96) .215
In-hospital mortality 2 (0.7%) 7 (2.6%) 40 (15.6%) b.001
BMI indicates body mass index; GFR, glomerular filtration ratio; AMI, acute myocardial infarction; EF, ejection fraction; HbA1c, glycosylated hemoglobin;
ESR, erythrocyte sedimentation rate; hs-CRP, high-sensitivity C-reactive protein; AST, aspartate aminotransferase; ALT, alanine aminotransferase; GGT,
γ-glutamyl transferase.
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myocardial infarction, blood lactate was a predictor of
shock development [17].
Beside, in our series, lactate concentrations were related
also to glucose values, which are known as prognostic indi-
cators for early mortality in patients with STEMI [14,18,19].
Lactate is the end product of glucose metabolism, but inFig. 1 Lactate values according to Killip class.disease states, hyperglycemia alone is not enough to modify
blood lactate concentrations. Although lactate increases after
glucose administration in healthy and surgical subjects [20-
22], Lund et al [23], who studied surgical patients to longer
intraoperative times and greater degree of stress, did not find
any increase in circulating lactate concentrations after intra-
venous glucose administration. In patients with severe sepsis
and CS, Revelly et al [16] observed that endogenous glucose
production was markedly increased, but it was not influenced
by lactate infusion. In this context, the counterregulatory
response, as well inflammatory mediators, may have con-
tributed to glycolysis and increased lactate production.Table 3 Multivariable linear regression analysis
Outcome: admission lactate
Unstandardized SE Standardized P
Killip class 0.58 0.18 0.21 .001
Admission
glycemia
1.06 0.20 0.30 b.001
Peak Tn I 0.003 0.001 0.217 b.001
Constant 0.56 0.95 .56
r2 = 0.320; P b .001.
Table 4 Multivariable backward logistic regression analysis
according to Killip classes
Killip class I-II
OR 95% CI P
Age (1-y step) 1.11 1.02-1.20 .014
Tn I 1.006 1.003-1.009 b.001
Leukocytes (1000/mL step) 1.20 1.01-1.40 .033
Killip class III-IV
OR 95% CI P
Lactate (1 mmol/L step) 1.17 1.05-1.30 .003
Age (1-y step) 1.11 1.03-1.19 .006
Leukocytes (1000/mL step) 1.17 1.03-1.33 .015
Adjusted for EF and glycemia.
Pseudo r2, 0.49; Hesmer-Lemershow goodness-of-fit χ2, 5.35; P = .720.
Adjusted for PCI failure.
Pseudo r2, 0.37; Hesmer-Lemershow goodness-of-fit χ2, 3.25; P = .917.
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understood in acute myocardial ischemia, the tight connec-
tion between glucose and lactate metabolism we observed in
patients with STEMI may underscore the clinical relevance
of glucose management in these patients [18] also taking into
the potential role of acute insulin resistance and insulin
therapy [24].
In conclusion, according to our data, in patients with
STEMI submitted to primary PCI, blood lactate is a
prognostic marker for early mortality only in the subgroup
with advanced Killip class. The degree of hemodynamic
impairment (as indicated by Killip class), of myocardial
ischemia (as inferred by Tn I), and glucose values are the
main factors influencing lactate concentrations in the early
phase of STEMI.References
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